Institute for Cancer Research

CIS Program Special Projects

Funding Opportunity Number

PICR-CIS-FY2024-01

Funding Opportunity Title

CIS PROGRAM SPECIAL PROJECTS

Key Dates

Events Cycle 1
Announcement

December 18, 2023
Due Open deadline until April 15, 2024; first come, first served
Award Amount

Varies

Administrative Contact

Kim Sagendorf (ksagendorf@purdue.edu)

Funding Opportunity Description 

The CIS Program of the Purdue Institute for Cancer Research would like to allocate funds to support the following project options:

CIS intends to make several awards at the $10,000 - $15,000 level or two awards at the $20,000 - $25,000 level this academic year. 

This is on a first come, first served basis until funds are expended. Funding criteria include cancer relevance, inter- and intra- programmatic collaborations, and technical innovations.

CLICK HERE to submit your electronic application by 5 pm on the cycle due date - no exceptions. The electronic submission system will not allow applications beyond the deadline. Once here you can enter your Purdue e-mail and password. 

Qualifications/Restrictions

Applicants must be current members of the Purdue University Institute for Cancer Research's Cell Identity and Signaling (CIS) program.

Cost share

This announcement does not require cost sharing.

Funds Available and Anticipated Number of Awards

The number of awards is contingent upon cancer institute endowments, gifts and other funds and the submission of meritorious applications.

Award Budget

The proposal will be funded at a level appropriate for the proposed work. See restrictions.

Award Project Period

It is expected that work will commence within less than two (2) months of the date of award.  A project period of no more than six (6) months will be assigned to projects. If funds are not spent by 10/31/2024, funds will be returned to the Purdue Institute for Cancer Research.

Award Restrictions

The budget cannot be used for PI salary support, clerical staff support, travel or equipment.

Award Requirements

Acceptance of an award will indicate your willingness to serve on the Institute's Pilot Grants Review Committee and to possibly represent the Institute at the annual Indiana Elks Convention.  The awardee MUST acknowledge the cancer institute. Suggested publication acknowledgement:

“The authors gratefully acknowledge the <insert shared resource name> and support from the Purdue University Institute for Cancer Research, P30CA023168”

No Cost Extension (NCE)

No cost extensions are not allowed.  If funds are not spent by 10/31/2024, funds will be returned to the Purdue Institute for Cancer Research.

Regulatory

Please note the award is contingent upon obtaining all of the necessary regulatory approvals (e.g., IRB, IACUC, PACUC) or a Memorandum of Understanding (MOU) pertaining to the work that has pending approvals.

Reporting

Responding to periodic request of progress is required.  Triage of future applications may occur if reporting requests are ignored.

Proposal Guidelines:

  1. Proposal Length: The proposal should be single-spaced and a maximum of two pages in length (Arial, 11pt) with no less than 0.5 inch margins.
  2. Required Proposal Structure:
    1. Significance
    2. Innovation
    3. Collaborative features
    4. Plans for proposal submission and manuscript preperation for publications
    5. Budget justification for total project cost

Announcement History and Updates

Funding Opportunity Number Summary of Change
PICR-CIS-FY2024-01 Initiation of Announcement